Pediatrics Doctors in Zeeland, MI Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Charlotte Jean Worpel, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8333 Felch St, Suite 200, Zeeland, MI 49464 Phone: 616-748-2850

Carrie Elizabeth Kastein, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8333 Felch St Ste 200, Zeeland, MI 49464 Phone: 616-748-2850

Dr. Danielle Diane Spilotro, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8333 Felch Street, Zeeland, MI 49464 Phone: 616-748-2850    Fax: 616-748-2855

Dr. Paul James Spilotro, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8333 Felch St, Suite 200, Zeeland, MI 49464 Phone: 616-772-7530    Fax: 616-748-3654

News Archive

Study: Women receiving social support during pregnancy less likely to develop postpartum depression

Women who receive strong social support from their families during pregnancy appear to be protected from sharp increases in a particular stress hormone, making them less likely to develop postpartum depression, according to a new study published in Clinical Psychological Science, a journal of the Association for Psychological Science.

Taming chronic cough

Chronic cough – often causing much discomfort, frustration, irritability and sleep disturbances in 10 percent to 20 percent of adults – is one of the leading reasons for consultation with a physician according to a report published this month in Annals of Allergy, Asthma & Immunology , the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

Next generation intermittent urinary catheters

Rochester Medical Corporation (NASDAQ:ROCM) today announced the introduction of Magic3(TM), its new line of intermittent urinary catheters.

NCI awards Soligenix $300,000 SBIR grant for orBec Phase 2 chronic GI GVHD trial

Soligenix, Inc., a development stage biopharmaceutical company, announced today that the National Cancer Institute has awarded Soligenix a Small Business Innovation Research grant to support the conduct of a Phase 2 clinical trial designed to evaluate orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestation of chronic Graft-versus-Host disease.

Genous Bio-engineered R stent beneficial for patients not suitable for long term DAPT

OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.

Read more Medical News

› Verified 6 days ago